During the past decade, U.S. Renal Care Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "U.S. Renal Care Inc." are "Pruritus" (2 trials) and "Uremic Pruritus" (2 trials). Many other conditions were trialed in "U.S. Renal Care Inc." in a lesser frequency.

Most popular intervention types in "U.S. Renal Care Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo tablets BID" (1 trials), "nalbuphine HCl ER" (1 trials), "nalbuphine HCl ER tablets 120mg BID" (1 trials) and "nalbuphine HCl ER tablets 60 mg BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "U.S. Renal Care Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "U.S. Renal Care Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in U.S. Renal Care Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in U.S. Renal Care Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".